Inhibitory Activity on Dog Bladder Cancer Organoids by Lanostane-type Triterpenes from Inonotus obliquus and Reinvestigation of Their NMR Assignments

Clicks: 13
ID: 332113
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #800 of 811 articles by views in phytochemistry letters

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 811 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Dog bladder cancer organoids (DBCO) serve as a model of human muscle-invasive bladder cancer (MIBC), for which suitable human organoid models remain limited. Inonotus obliquus (Chaga) extract reportedly reduces DBCO growth, but its active constituents were unidentified. We isolated four lanostane-type triterpenes from Chaga extract through fractionation guided by DBCO viability and revised their previous NMR assignments. All compounds reduced DBCO viability at 21.8 µM (10 µg/mL), with compound 3 showing the greatest potency, suggesting that C-21/C-24 stereochemistry may influence cytotoxicity.
Reference Key
openalex_W7221512179 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Wai Lam Tse, Mohamed Elbadawy, Haru Yamamoto, Ting Wei Yu, Tatsuya Usui, Kazuaki SASAKI, Yuta Shinohara, Fumiaki Nakamura, Koshi Machida, Yoichi Nakao
Journal phytochemistry letters
Year 2026
DOI
10.1093/chemle/upag198
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.